ID   WEHI-3B/CPX
AC   CVCL_3430
SY   WEHI-3B/CPXRES
DR   CLO; CLO_0009582
DR   CLDB; cl4938
DR   ICLC; ATL99004
DR   Wikidata; Q54993763
RX   CelloPub=CLPUB00272;
RX   PubMed=17635523;
CC   Selected for resistance to: ChEBI; CHEBI:100241; Ciprofloxacin (CIP).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
RX   CelloPub=CLPUB00272;
RA   Pessina A., Mineo E., Gribaldo L., Mancina G., Neri M.G., Moran E.,
RA   Cleary I., Clynes M.;
RT   "Susceptibility of leukemia cell lines to quinolones and induction of
RT   resistance to ciprofloxacin in WEHI-3B(D+) leukemia cells.";
RL   Cancer J. 6:291-297(1993).
//
RX   PubMed=17635523; DOI=10.1111/j.1365-2184.2007.00456.x;
RA   Pessina A., Bonomi A., Casati S., Collotta A., Croera C.,
RA   Marafante E., Palitti F., Gribaldo L.;
RT   "Mitochondrial function, apoptosis and cell cycle delay in the WEHI-3B
RT   leukaemia cell line and its variant Ciprofloxacin-resistant
RT   WEHI-3B/CPX.";
RL   Cell Prolif. 40:568-579(2007).
//